[Chickenpox and shingles: one virus, two diseases and current vaccination recommendations in Switzerland].
Adults, pregnant women, premature babies and immunocompromised persons are at increased risk for varicella complications. Therefore the current Swiss vaccination recommendations against varicella include a general recommendation for 11 to 15 year old adolescents with a negative varicella history, as well as a specific recommendation for risk groups. The goal of both recommendations is to reduce varicella complications in persons most at risk. The vaccine is not universally recommended for all toddlers in Switzerland, while this is the case in some countries such as the United States. Pros and cons of different vaccination strategies, as well as possible short- and long-term effects on herpes zoster incidence are taken into account. In the United States, there was a marked decline in incidence and hospitalisations, but an increased herpes zoster incidence in the short term. Finally, public health aspects of herpes zoster, post-herpetic neuralgia and possible vaccination strategies are outlined.
1 Abteilung Übertragbare Krankheiten MT, Bundesamt für Gesundheit BAG, Bern.
Nadine
N
Eckert
1 Abteilung Übertragbare Krankheiten MT, Bundesamt für Gesundheit BAG, Bern.
Virginie
V
Masserey Spicher
D000293:Adolescent; D000328:Adult; D002644:Chickenpox / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D019433:Chickenpox Vaccine / Q000008:administration & dosage* / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D005260:Female; D006562:Herpes Zoster / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D053061:Herpes Zoster Vaccine / Q000008:administration & dosage / Q000276:immunology; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D007117:Immunization, Secondary; D007223:Infant; D007231:Infant, Newborn; D009894:Opportunistic Infections / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control; D011247:Pregnancy; D012307:Risk Factors; D013557:Switzerland
D019433:Chickenpox Vaccine; D053061:Herpes Zoster Vaccine